We recently compiled a list of the 12 Best Low-Priced Pharma Stocks to Buy Right Now. Organon & Co. (NYSE:OGN) is one of the ...

What the TOFIDENCE approval means for Organon stock The latest catalyst for Organon (OGN) is the FDA approval of a supplemental Biologics License Application for TOFIDENCE, which broadens its use to ...

Looking ahead to 2030, our model projects OGN could trade at an average price of $27.19, with a potential range between $20.39 and $33.99. This represents a potential 101.3% return from today's price.

Organon (OGN) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the ...

The company has submitted a Form DEFM14A to the SEC, indicating an upcoming shareholder vote. This form gives shareholders all the information they need to develop an informed vote. Read on to learn ...

Detailed price information for Origin Enterprises Plc (ORENF) from The Globe and Mail including charting and trades.

Organon (OGN) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Shares ...

This video follows a taste test of some of the most praised burgers and sandos on earth. Each one has to prove whether the hype comes from the meat, bread, sauce, texture, or the way every layer works ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock ...

Organon & Co. is a science based global pharmaceutical company, which develops and delivers innovative health solutions through a portfolio of prescription therapies within women’s health, biosimilars ...

(OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Orogen ...

High nominal interest rates, and the perceived “hawkishness” of the new U.S. Federal Reserve, has led to a very strong U.S. dollar, and price weakness in other currencies, and things priced in dollars ...